Skip to main content
Log in

Primary malignant melanoma of the penis: a case report

  • Case Report
  • Published:
Medical Oncology Aims and scope Submit manuscript


We present the case of a patient with malignant melanoma of the glans penis and urethral meatus, which was found in a 60-year-old man with non-healing ulcerative penile lesion and bilateral clinically palpable inguinal lymphadenopathies at diagnosis. A diagnostic biopsy showed the characteristics of a malignant melanoma. Incisional biopsies from the cutaneous lesions on his glans penis and urethra were performed. Histopathological examination of both specimens showed generally ulceronecrotic surface and numerous atypical melanocytic cells. The diagnosis of giant cell melanoma was made. Two months later, bilateral inguinal lymph nodes dissection was performed. Histopathological examination of both specimens demonstrated malignant melanoma metastasis. Three months after the diagnosis, the patient underwent partial penectomy. High-dose interferon-alpha-2b treatment was started. Early diagnosis is of paramount importance, as the prognosis becomes very poor with an advanced tumor stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3


  1. Stillwell TJ, Zincke H, Gaffey TA, Woods JE. Malignant melanoma of the penis. J. Urol. 1988;140:72–5.

    PubMed  CAS  Google Scholar 

  2. Gross SD. A system of surgery. 6th ed. Philadelphia: W. B. Saunders; 1882.

    Google Scholar 

  3. Tallerman A. Malignant melanoma of the penis. Urol Int. 1972;27:66–80.

    Article  PubMed  CAS  Google Scholar 

  4. Rogers RS 3rd, Gibson LE. Mucosal, genital, and unusual clinical variants of melanoma. Mayo Clin Proc. 1997;72(4):362–6.

    Article  PubMed  Google Scholar 

  5. Hankins CL, Kotwal S, Majumder S, Weston P, Phipps A, Anathhanam AJ. Multifocal melanoma of the glans penis. Plast Reconstr Surg. 2006;118:33e–8e.

    Article  PubMed  Google Scholar 

  6. Manivel JC, Fraley EE. Malignant melanoma of the penis and male urethra: 4 case reports and literature review. J Urol. 1988;139:813.

    PubMed  CAS  Google Scholar 

  7. Oldbring J, Mikulowski P. Malignant melanoma of the penis and male urethra: report of nine cases and review of the literature. Cancer. 1987;59:581.

    Article  PubMed  CAS  Google Scholar 

  8. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7–17.

    PubMed  CAS  Google Scholar 

  9. Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2- KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol. 2001;19:2370–80.

    PubMed  CAS  Google Scholar 

  10. Sanchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol. 2005;173:1958–65.

    Article  PubMed  CAS  Google Scholar 

  11. DeBree E, Sanidas E, Tardi M, Gaki B, Tsiftsis D. Malignant melanoma of the penis. Eur J Surg Oncol. 1997;23:277–99.

    Article  CAS  Google Scholar 

  12. van Geel AN, den Bakker MA, Kirkels W, Horenblas S, Kroon BB, de Wilt JH, et al. Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology. 2007;70:143–7.

    Article  PubMed  Google Scholar 

  13. De Giorgi V, Grazzini M, Massi D, Rossari S, Gori A, Janowska A, Bruscino N, Lotti T. Melanoma of the penis: a clinical dermoscopic case study. Acta Derm Venereol. 2010;90(1):87–8.

    Article  PubMed  Google Scholar 

  14. Tritton SM, Shumack S, Fischer G. Fatal delayed presentation of primary melanoma of the penis. Australas J Dermatol. 2008;49(4):239–41.

    Article  PubMed  Google Scholar 

  15. Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and lowdose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol. 2000;18(12):2444–50.

    PubMed  CAS  Google Scholar 

  16. Eggermont AMM, Suciu S, MacKie R, et al. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet. 2005;366(9492):1189–96.

    Article  PubMed  CAS  Google Scholar 

  17. Pehamberger H, Soyer HP, Steiner A, et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol. 1998;16(4):1425–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Gamze Gokoz Dogu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dogu, G.G., Yaren, A., Tuncay, L. et al. Primary malignant melanoma of the penis: a case report. Med Oncol 29, 1300–1303 (2012).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: